首页> 外文期刊>Journal of Enam Medical College >Pattern of Anti-Microbial Sensitivity and Resistance against Salmonella Species in a Tertiary Hospital in Dhaka
【24h】

Pattern of Anti-Microbial Sensitivity and Resistance against Salmonella Species in a Tertiary Hospital in Dhaka

机译:达卡一家三级医院的抗菌敏感性和沙门氏菌抵抗力模式

获取原文
       

摘要

Background: Drug resistant Salmonella spp. continues to remain a health problem as last two decades have witnessed the emergence and spread of multidrug resistance against conventional anti-typhoid drugs. Multidrug resistant (MDR) typhoid is now a serious problem in many developing countries including Bangladesh.Objectives: To find out antimicrobial sensitivity and resistance patterns of different types of Salmonella spp. in patients with enteric fever and to find out the epidemiological strains (e.g. resistant strain, epidemic strain, MDR strain) in patients with enteric fever.Materials and Methods: This cross-sectional study was done during October 2009–November 2010 and January–December 2012 at United Hospital Limited, Dhaka. Laboratory reports of blood culture were collected from those patients who were investigated as suspected cases of enteric fever. Both the indoor and outdoor patients were enrolled in the study. Salmonella species resistant to one or more of the first line drugs were divided into resistant strain, epidemic strain and multi-drug resistant strain.Results: During the period October 2009–November 2010, total 210 subjects were enrolled. Among the participants, 122 were male and 88 were female. S. typhi were found in 133 samples whereas 76 were S. paratyphi A and only 1 S. paratyphi B. Sensitivity was found 77% for ampicillin, 91.4% for cotrimoxazole, 78.6% for chloramphenicol, 87.6% for ciprofloxacin, 96.6% for cefixime, 98% for ceftriaxone and only 22.1% for azithromycin (77.9% resistant). Total 91 (43.3%) cases were found having resistant strain, 6 (2.8%) epidemic strain and 8 (3.8%) MDR strain Salmonella spp. The sensitivity of azithromycin was analyzed among different categories of strains and revealed that 52.7% showed resistance in resistant strain, 100% in epidemic strain and 87.5% in MDR strain. During the period between January–December 2012, total 139 subjects were enrolled. Among the participants 68 were male and 71 were female with a ratio of 1:1.04. S. typhi were found in 84 cases whereas 55 were S. paratyphi A and no S. paratyphi B. Sensitivity was found 62.7% for ampicillin, 82% for cotrimoxazole, 83% for chloramphenicol, 45.2% for azithromycin, 95% for ciprofloxacin, 99.3% for cefixime and 100% for ceftriaxone. Total 55 (39.6%) cases were found having resistant strain, 3 (2.1%) epidemic strain and 17 (12.2%) MDR strain Salmonella spp. Against azithromycin 67.3% showed resistance in resistant strain, 33.3% in epidemic strain and 29.4% in MDR strain.Conclusion: The policy of empirical treatment of enteric fever needs to be rationalized and newer generation antibiotics should be restricted only for multi-resistant cases of enteric fever.J Enam Med Col 2015; 5(2): 88-92
机译:背景:耐药沙门氏菌。由于过去二十年来目睹了针对常规抗伤寒药物的多药耐药性的出现和扩散,因此仍然继续存在健康问题。目前,在包括孟加拉国在内的许多发展中国家,耐多药性伤寒是一个严重的问题。目的:找出不同类型沙门氏菌的抗菌敏感性和耐药模式。肠热患者的流行病学菌株(例如耐药菌株,流行病菌株,MDR菌株)。材料与方法:这项横断面研究于2009年10月至2010年11月以及1月至12月进行2012年,达卡联合医院有限公司。从那些被怀疑为肠热的患者中收集了血液培养的实验室报告。室内和室外患者均参加了研究。对一种或多种一线药物产生抗药性的沙门氏菌分为抗药性菌株,流行性菌株和多药抗药性菌株。结果:2009年10月至2010年11月期间,共招募了210名受试者。在参与者中,男性为122位,女性为88位。在133个样本中发现伤寒沙门氏菌,而副伤寒沙门氏菌76个,仅1个副伤寒沙门氏菌。氨苄西林的敏感性为77%,曲美唑为91.4%,氯霉素为78.6%,环丙沙星为87.6%,头孢克肟为96.6% ,头孢曲松钠为98%,阿奇霉素仅为22.1%(耐药率为77.9%)。共发现91例(43.3%)耐药菌株,6例(2.8%)流行菌株和8例(3.8%)MDR菌株沙门氏菌。分析了不同种类菌株对阿奇霉素的敏感性,结果显示耐药菌株中有52.7%的耐药性,流行病菌株中有100%的耐药性,MDR菌株中有87.5%的耐药性。在2012年1月至12月之间,总共招募了139名受试者。在参与者中,男性为68位,女性为71位,比例为1:1.04。发现84例伤寒沙门氏菌,而副伤寒沙门氏菌55例,无副伤寒沙门氏菌。氨苄西林的敏感性为62.7%,曲美唑为82%,氯霉素为83%,阿奇霉素为45.2%,环丙沙星为95%,头孢克肟为99.3%,头孢曲松钠为100%。共发现55例(39.6%)耐药菌株,3例(2.1%)流行菌株和17例(12.2%)MDR菌株沙门氏菌。对阿奇霉素的耐药菌株中有67.3%表现出耐药性,流行病菌株中表现出33.3%,MDR菌株中表现出29.4%。结论:肠胃热的经验性治疗政策应合理化,仅对多耐药病例应限制使用新一代抗生素肠热.J Enam Med Col 2015; 5(2):88-92

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号